Skip to Content

Jiangsu Baozong & Baoda Pharmachem, China, 2024

GMP Audit Report

Company
Jiangsu Baozong & Baoda Pharmachem

Product(s)
Flubendazole

Country
China

Audit Year
2024

0.00 € 0.00 €
0.00 €